Emerging evidence demonstrates that GLP-1 receptors are expressed in Type II taste cells, where they modulate sweet sensitivity through the G-gustducin/TRPM5 pathway, and downregulate T1R2/T1R3 expression and ATP release (1, 15)
This foundational immune support can potentially reduce the frequency, severity, and unpredictability of MCAS flares and histamine-driven allergic responses
Crossing the bloodbrain barrier: recent advances in drug delivery to the brain
Brain and Cognitive Health BPC-157 is evidenced to have neuroprotective properties, attenuating damage due to strokes and central nervous system injuries while balancing neurotransmitters to combat symptoms of depression, Parkinsons disease, and schizophrenia [2, 11, 34]
Thus, loss of FBF-1 and FBF-2 has a much less severe and later effect on GSC maintenance than loss of niche signaling or loss of the niche targets, confirming the notion of some missing self-renewal regulator (gene X, Figure 1A)